These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16113662

  • 1. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shin HJ, Chung JS, Cho GJ.
    Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
    [No Abstract] [Full Text] [Related]

  • 2. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC.
    Cancer; 2009 Feb 01; 115(3):561-70. PubMed ID: 19117346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318
    [Abstract] [Full Text] [Related]

  • 8. Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Nishiwaki S, Miyamura K, Kato C, Terakura S, Ohashi K, Sakamaki H, Nakao S, Harigae H, Kodera Y.
    Anticancer Res; 2010 Jun 15; 30(6):2415-8. PubMed ID: 20651401
    [Abstract] [Full Text] [Related]

  • 9. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia.
    Cho BS, Kim HJ, Lee S, Eom KS, Min WS, Lee JW, Kim CC.
    Eur J Haematol; 2007 Aug 15; 79(2):170-3. PubMed ID: 17608710
    [Abstract] [Full Text] [Related]

  • 10. [Outcome of autologous hematopoietic stem cell transplantation in combination with imatinib for 16 cases of Philadelphia chromosome positive acute lymphoblastic leukemia].
    Liu X, Jiang E, Huang Y, Yang D, Pang A, Wei J, Ma Q, Zhang R, Qiu L, Feng S, Han M.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar 15; 35(3):250-2. PubMed ID: 24666497
    [No Abstract] [Full Text] [Related]

  • 11. [Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib].
    Han W, Liu KY, Xu LP, Chen H, Liu DH, Chen YH, Zhang XH, Zhang YC, Chen Y, Wang Y, Wang J, Lu DP, Huang XJ.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1974-7. PubMed ID: 19062738
    [Abstract] [Full Text] [Related]

  • 12. Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Peters SO, Stockschläder M, Hegewisch-Becker S, Krüger W, Weh HJ, Hossfeld DK, Zander AR.
    Bone Marrow Transplant; 1995 May 22; 15(5):783-4. PubMed ID: 7670406
    [Abstract] [Full Text] [Related]

  • 13. What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?
    Mele G, Pinna S, Melpignano A, Romano A, Brocca MC, Coppi MR, Quarta G.
    Leuk Res; 2007 Oct 22; 31(10):1445-7. PubMed ID: 17462730
    [Abstract] [Full Text] [Related]

  • 14. [Treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Yanada M.
    Nihon Rinsho; 2007 Jan 28; 65 Suppl 1():479-82. PubMed ID: 17474451
    [No Abstract] [Full Text] [Related]

  • 15. Multiple intracranial tumors in Philadelphia chromosome positive acute lymphoblastic leukemia: successful treatment following aggressive supportive care, early cranial radiation, high dose chemotherapy and imatinib.
    Cuvelier GD, Vitali AM, Ford JC, Dix DB.
    Pediatr Blood Cancer; 2008 Jul 28; 51(1):135-7. PubMed ID: 18383153
    [Abstract] [Full Text] [Related]

  • 16. [Autologous bone marrow transplantation in acute lymphoblastic leukemia].
    Tura S, Visani G, Gamberi B.
    Haematologica; 1991 Jun 28; 76 Suppl 3():327-36. PubMed ID: 1684347
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.
    Visani G, Piccaluga P, Malagola M, Isidori A.
    Leukemia; 2009 Sep 28; 23(9):1687-8. PubMed ID: 19421228
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
    Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Nishii K, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Narimatsu H, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R, Japan Adult Leukemia Study Group.
    Haematologica; 2008 Feb 28; 93(2):287-90. PubMed ID: 18223280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.